...
首页> 外文期刊>The Neurohospitalist >Neurological Prognostication of Cardiac Arrest in an Era of Extracorporeal Membrane Oxygenation
【24h】

Neurological Prognostication of Cardiac Arrest in an Era of Extracorporeal Membrane Oxygenation

机译:体外膜氧合时代心脏骤停的神经学预测

获取原文
获取原文并翻译 | 示例

摘要

A neuron-specific enolase level greater than 33 ng/mL at days I to 3 or status myoclonus within I day are traditional indicators of poor neurological prognosis in survivors of cardiac arrest. We report the case of a 70-year-old man who received extracorporeal membrane oxygenation following cardiac arrest. Despite having both an elevated neuron-specific enolase concentration of 68 ng/mL and status myoclonus, he made an excellent neurological recovery. The value of traditional markers of poor prognosis such as elevated neuron-specific enolase or status myoclonus has not been systematically validated in patients treated with extracorporeal membrane oxygenation or therapeutic hypothermia. Straightforward application of practice guidelines in these cases may result in tragic outcomes. This case underscores the need for reliable prognostic markers that account for recent advances in cardiopulmonary and neurological therapies.
机译:在Day I至3天或9天内的神经元特异性烯醇酶水平大于33ng / ml,是在i日内的状态肌键是心脏骤停幸存者神经系统预后不良的传统指标。 我们举报了在心脏骤停后接受体外膜氧合的70岁男性的案例。 尽管具有68ng / ml和状态肌阵挛的神经元特异性特异性浓度升高,但他使神经促进的神经荷松。 在用体外膜氧合或治疗性低温治疗的患者中,尚未系统地验证了预后不良预后的传统标志物的价值。 在这些情况下,直接应用实践指南可能导致悲惨的结果。 这种情况强调了需要可靠的预后标志物,其考虑有心肺和神经疗法的最新进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号